Iofina heads for record year as iodine output and profits beat forecasts

Iofina delivered a record 743.2 tonnes of crystalline iodine in 2025, up 17.2% year‑on‑year (Q4: 221.8t vs 194.1t), and expects 2025 revenues to exceed $65m with EBITDA above $11m; net cash rose to $5.2m from $2.9m a year earlier. Strong iodine spot prices (above $70/kg through 2025) and robust second‑half sales drove the outperformance, while guidance calls for 325–355t in H1 2026 and construction of a Permian Basin plant (50,000 bbl/day capacity) due to start producing 170–220t/year when fully commissioned in H2 2026.

Analysis

Market structure: Iofina (AIM:IOF / OTC:IOFNF) is the clear direct beneficiary — 2025 output 743.2 t and a Permian plant adding 170–220 tpa implies a 23–30% incremental supply to its base, which can lift revenues by roughly $12m/year at $70/kg. Winners also include Permian midstream operators and specialty chemical tollers; losers are end-users (radiopharma, electronics chemistries) with limited ability to pass through costs, pressuring margins downstream.

Risk assessment: Key tail risks are regulatory action on brine disposal or a major plant HSE incident, a >3‑6 month commissioning delay, or a rapid iodine price collapse (>30%) from new global capacity or demand shocks. Time buckets: immediate (days/weeks) watch cash, inventory and spot iodine; short (months) watch H1 2026 production guidance (325–355 t) and Q1 cashflow; long (H2 2026+) the Permian ramp and capex execution dictate re-rating. Hidden dependency: iodine economics are tightly coupled to oilfield brine volumes and US oil output/seasonality.

Trade implications: Direct play is a sized equity long in IOF ahead of H2 2026 commissioning with a protective hedge (see decisions). If liquid, use Jan‑2027 call spreads to lever upside with capped risk; pair trade by going long IOF and short the Materials ETF (XLB) to hedge macro materials moves. Cross-asset: persistent strong iodine supports small-cap credit improvement for producers (tighter spreads) and should slightly reduce volatility premia in related equity options if execution risk falls.

Contrarian angles: Consensus underestimates execution and opex scaling — Permian plant doubling process scale raises capex/cost overrun risk and extension of payback if iodine falls below ~$55/kg. Historical analogs (rare minerals booms) show price spikes attract rapid capacity or substitution, so treat current >$70/kg spot as vulnerable; unintended consequence: high prices accelerate recycling/substitution, capping long-term pricing power.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Iofina (AIM:IOF / OTC:IOFNF) within 30 days to capture H2 2026 Permian plant upside; target partial trim at +30% and full reduce at +60%; hard stop-loss at -20%.
• If equity options are available, purchase a Jan‑2027 call spread on IOF sized 0.5–1% notional (long strike ≈ current+30%, short strike ≈ current+80%) to limit downside while keeping upside; if no options, buy 12‑month protective puts (cost ~0.5% notional) to cap tail risk. Close these hedges if iodine spot < $55/kg or company confirms plant on-stream within contracted schedule.
• Implement a relative-value hedge: long IOF 1.5% notional vs short Materials ETF (XLB) 1.0% notional to isolate iodine-specific gains; rebalance or unwind the short if correlation IOF:XLB drops below 0.2 or on successful plant commissioning.
• Monitor four stop/go catalysts in next 90–180 days and act decisively: (1) Q1 2026 production vs guidance (watch for >10% miss), (2) any state/Federal filings on brine disposal (reduce position 50% on adverse rulings), (3) quarterly net cash falling below $3m (exit), and (4) first commercial output from Permian plant in H2 2026 (add to position if on time and producing within 10% of target).